分期与同期颈部分支重建优化胸主动脉腔内修复近端锚定区的结局比较
该回顾性单中心研究纳入2010至2023年因优化TEVAR近端锚定区而行颈部分支重建的148例患者,比较分期(112例)与同期(36例)策略。两组主要不良事件率无显著差异(34.8% vs 38.9%,P=0.692),但分期组心肌梗死、呼吸并发症、脑血管意外及出血并发症有更低的趋势(均未达统计学显著)。作者认为两种策略均安全,应根据患者临床表现个体化选择。
要点
- 分期与同期颈部分支重建联合TEVAR的主要不良事件率无显著差异。
- 同期组非择期手术比例(44.4% vs 18.8%)和0区TEVAR释放比例(5.5% vs 0%)均高于分期组。
- 颈部分支重建技术成功率99.4%,5年一期、一期辅助及二期通畅率两组无差异。
核心结论
- 分期与同期颈部分支重建联合TEVAR的围手术期结局在统计学上相似,尽管同期手术更常在非择期情况下进行。
- 分期策略在临床上显示出更好结局的趋势。
- 颈部分支重建技术成功率高且中期通畅率良好,目前两种策略均看似安全,应根据患者临床表现个体化选择。
研究设计与样本
- 回顾性单中心研究,纳入2010至2023年因优化TEVAR近端锚定区而行颈部分支重建的患者。
- 排除主动脉干预后 salvage 颈部分支重建或颈部分支重建后行开放主动脉修复的患者。
- 共148例患者符合标准,实施162例颈部分支重建手术;分期112例(75.7%),同期36例(24.3%)。
- 颈部分支重建定义为主动脉弓血管(包括椎动脉)的旁路或移位术。
主要发现
- 分期组有3例(2.7%)因颈部分支重建并发症未行TEVAR。
- 同期组较分期组更常为非择期修复(44.4% vs 18.8%,P=0.004)和0区TEVAR释放(5.5% vs 0%,P=0.042)。
- 总体主要不良事件率为35.8%(n=53),分期组与同期组无差异(34.8% vs 38.9%,P=0.692)。
- 分期组心肌梗死(2.7% vs 8.3%,P=0.155)、呼吸并发症(16.1% vs 30.6%,P=0.089)、脑血管意外(11.6% vs 22.2%,P=0.167)和出血并发症(10.7% vs 22.2%,P=0.095)发生率较低,但均未达统计学显著。
- 总体神经损伤率为5.4%,分期组与同期组无差异(4.5% vs 8.3%,P=0.403);颈部分支重建总体技术成功率为99.4%(n=161),两组无差异(99.1% vs 100%,P=0.998);5年内一期、一期辅助及二期通畅率两组无差异。
关键数值与推荐
- 主要不良事件为复合终点,包括30天死亡、心肌梗死、呼吸衰竭、脑血管意外、血肿/出血、并发症、神经损伤、乳糜漏和急性肾损伤。
临床怎么用
- 作者认为目前分期与同期策略均看似安全,应根据患者临床表现个体化选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cervical debranching was traditionally performed for occlusive disease of the proximal cervical branches of the aortic arch. However, as endovascular technology has evolved, cervical debranching is more commonly performed to optimize proximal landing zones for thoracic endovascular aortic repair (TEVAR). Cervical debranching and TEVAR can be performed in either a staged or synchronous fashion with little-to-no data regarding the optimal treatment strategy. Therefore, the purpose of this study was to evaluate outcomes of patients undergoing cervical debranching and TEVAR in a staged vs synchronous fashion. METHODS: This was a retrospective single-center review of patients undergoing cervical debranching to optimize proximal landing zones for TEVAR from 2010 to 2023. Patients were excluded if they had a salvage cervical debranching following an aortic intervention or had an open aortic repair following cervical debranching. Patients were stratified on whether the cervical debranching and TEVAR were staged or synchronous. Cervical debranching was defined as a bypass or transposition of the vessels of the aortic arch (including vertebral artery). The primary outcome was major adverse events (MAEs), which was a composite variable consisting any of the following: 30-day mortality, myocardial infarction, respiratory failure, cerebrovascular accident, hematoma/bleeding, complications, nerve injury, chyle leaks, and acute kidney injury. RESULTS: A total of 148 patients met study criteria, with 162 cervical debranching procedures performed. There were 112 staged (75.7%) and 36 synchronous (24.3%) patients. There were three patients (2.7%) in the staged cohort that were intended to be staged but did not undergo TEVAR due to complications of their cervical debranching procedure. Synchronous patients were more likely to have non-elective repairs (44.4% vs 18.8%; P = .004) and zone 0 TEVAR deployments (5.5% vs 0%; P = .042) than staged repairs. The overall rate of MAEs for the cohort was 35.8% (n = 53). There were no differences in MAEs between staged and synchronous patients (34.8% vs 38.9%; P = .692). Although not statistically significant, there were lower rates of myocardial infarctions (2.7% vs 8.3%; P = .155), respiratory complications (16.1% vs 30.6%; P = .089), cerebrovascular accidents (11.6% vs 22.2%; P = .167), and bleeding complications (10.7% vs 22.2%; P = .095) in the staged group. The rate of nerve injury for the total cohort was 5.4%, with no differences between the staged and synchronous cohorts (4.5% vs 8.3%; P = .403). The overall technical success rate for cervical debranching procedures was 99.4% (n = 161) with no differences between staged and synchronous procedures (99.1% vs 100%; P = .998). There were no differences in primary, primary-assisted, and secondary patency of the cervical debranching procedures over 5 years between staged and synchronous procedures. CONCLUSIONS: Staged and synchronous cervical debranching and TEVAR had statistically similar perioperative outcomes despite synchronous procedures being performed more often in the non-elective setting. However, there were clinically relevant trends toward better outcomes with staging. Cervical debranching can be performed with a high technical success rate with excellent mid-term patency. Currently, both staged and synchronous strategies appear to be safe and should be tailored towards patients' clinical presentations.
引用
- Khoury MK, Mulaney-Topkar B, Anjorin A, et al. Outcomes following staged versus synchronous cervical debranching to optimize proximal landing zones for thoracic endovascular aortic repair of the aortic arch. J Vasc Surg. 2025. PMID: 40258432. doi:10.1016/j.jvs.2025.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。